Skip to main content
Signal8

Okazaki Jason A

SEC insider (Form 3/4/5 filer). CIK 0001807214. CEO and President at ASSEMBLY BIOSCIENCES, INC. (ASMB). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 29, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Okazaki Jason A has filed insider reports for

  • ASSEMBLY BIOSCIENCES, INC. (ASMB): Director, Officer, CEO and President
Okazaki Jason A profile photo

Okazaki Jason A

CIK: 0001807214

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ASSEMBLY BIOSCIENCES, INC. logo
ASMB

ASSEMBLY BIOSCIENCES, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • ASSEMBLY BIOSCIENCES, INC. logo
    ASMB

    ASSEMBLY BIOSCIENCES, INC.

    Mar 29, 2026
    Award
    Direct
    50.8K shares-
  • ASSEMBLY BIOSCIENCES, INC. logo
    ASMB

    ASSEMBLY BIOSCIENCES, INC.

    Mar 31, 2025
    Sale
    Direct
    355 shares at avg. $9.85$3K
  • ASSEMBLY BIOSCIENCES, INC. logo
    ASMB

    ASSEMBLY BIOSCIENCES, INC.

    Mar 29, 2025
    Award

    Stock Option (right to buy)

    Direct
    71.1K shares-
  • ASSEMBLY BIOSCIENCES, INC. logo
    ASMB

    ASSEMBLY BIOSCIENCES, INC.

    Oct 3, 2024
    Sale
    Direct
    197 shares at avg. $14.81$3K

1-4 of 4